Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2V617F
Authors:
- 15 February 2007
- journal article
- Published by Springer Nature in Leukemia
- Vol. 21 (5) , 1128-1130
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocritHaematologica, 2007
- Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosisBlood, 2006
- The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia veraBlood, 2006
- Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disordersBlood, 2006
- Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disordersBlood, 2006
- Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosisLeukemia, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia veraThe Hematology Journal, 2004